Review and Meta-Analyses of the Effects of MLC601/MLC901 (NeuroAiD) on Post-Stroke Functional and Motor Recovery
Narayanaswamy Venketasubramanian, Tsong-Hai Lee, Hou Chang Chiu, Liang Guo, Christopher Li Hsian Chen · 2026
Read Review and Meta-Analyses of the Effects of MLC601/MLC901 (NeuroAiD) on Post-Stroke Functional and Motor Recovery by Narayanaswamy Venketasubramanian, Tsong-Hai Lee, Hou Chang Chiu, Liang Guo, Christopher Li Hsian Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13516714.txt.
Description
Narayanaswamy Venketasubramanian and four colleagues pool trial evidence on NeuroAiD, a natural product sold as MLC601 or MLC901, for stroke recovery in a 2026 meta-analysis. Drugs that aid rehabilitation after ischaemic stroke are scarce. The team gathered randomised trials comparing the product with placebo or standard care. Six papers covering seven trials fed the analysis, with about fifteen hundred patients scored for daily function and over seventeen hundred for movement.
Recovery favoured the product at one month and stayed ahead at six and twelve months, with gains lasting up to two years. Movement scores improved too, most strongly in the first two months. Patients with moderately severe strokes gained the most. Reports described the product as safe and well tolerated alongside standard care. The authors support starting it early with rehabilitation, while noting two trials carried unclear bias risk.
Catalog record
| CREATOR | Narayanaswamy Venketasubramanian, Tsong-Hai Lee, Hou Chang Chiu, Liang Guo, Christopher Li Hsian Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |